Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

GLP-1 medicines can be helpful tools for the treatment of obesity and for other important health goals, but they’re not for ...

Semaglutide and newer GLP-1 drugs help people lose substantially ... published last month in the journal Food Quality and ...

The following text highlights some of these precautions. Boxed warning: Risk of thyroid cancer Semaglutide (the active ingredient in Ozempic and Wegovy) has a boxed warning for a possible risk of ...

Semaglutide medications, like Ozempic and Wegovy, are more popular than ever. Millions of Americans have embraced them for ...

In animal studies, semaglutide (the active drug in Ozempic and Wegovy) has been shown to cause thyroid tumors and thyroid cancer. Doctors don’t know if it can cause thyroid cancers in people.

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

Animal studies have shown that using liraglutide (the active ingredient in Saxenda) or semaglutide (the active ingredient in Ozempic) may increase the risk of thyroid cancer. However, the risk of ...

The active drugs in Ozempic (semaglutide) and Mounjaro (tirzepatide) have caused thyroid cancer in animals. It’s not known whether these drugs can cause thyroid cancer in humans. But due to this ...